Publication | Closed Access
Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland
62
Citations
24
References
2001
Year
Specific InhibitorChemoprevention StrategyMedicinePharmacologyPharmacotherapyDrug DevelopmentEconomic EvaluationOncologyNew Cyclo-oxygenase 2Drug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1